This miRNA is downregulated in human glioblastoma tissues and cells in accordance with fibulin-3 upregulation, suggesting loss of its function may contribute to tumour progression and thus restoration of miR-338-5p could yield substantial therapeutic benefits. This evidence concerns the gene EFEMP1 and neoplasm.